ImmunityBio, Inc. (IBRX)
3.015
+0.20
(+6.91%)
USD |
NASDAQ |
Jan 14, 16:00
3.01
0.00 (0.00%)
After-Hours: 20:00
ImmunityBio EPS Diluted (Quarterly): -0.071 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Cytokinetics, Inc. | -2.552 |
| Altimmune, Inc. | -0.2126 |
| Seres Therapeutics, Inc. | 0.9353 |
| Relay Therapeutics, Inc. | -0.4301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.27M |
| Revenue (Quarterly) | 32.06M |
| Total Expenses (Quarterly) | 99.31M |
| Enterprise Value | 3.382B |
| Gross Profit Margin (Quarterly) | 87.12% |
| Profit Margin (Quarterly) | -209.8% |
| Earnings Yield | -13.95% |
| Normalized Earnings Yield | -14.92 |